Genpact Limited (NYSE:G) Short Interest Update

Genpact Limited (NYSE:GGet Free Report) was the recipient of a significant growth in short interest in the month of June. As of June 15th, there was short interest totalling 4,970,000 shares, a growth of 9.2% from the May 31st total of 4,550,000 shares. Based on an average trading volume of 1,520,000 shares, the short-interest ratio is currently 3.3 days. Approximately 3.0% of the shares of the company are short sold.

Insider Transactions at Genpact

In related news, Director N. V. Tyagarajan sold 1,000 shares of Genpact stock in a transaction on Wednesday, June 5th. The stock was sold at an average price of $33.17, for a total transaction of $33,170.00. Following the completion of the sale, the director now owns 7,300 shares of the company’s stock, valued at $242,141. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 2.80% of the company’s stock.

Institutional Investors Weigh In On Genpact

A number of institutional investors have recently bought and sold shares of G. Northern Trust Corp increased its stake in Genpact by 0.4% in the 3rd quarter. Northern Trust Corp now owns 1,251,019 shares of the business services provider’s stock worth $45,287,000 after buying an additional 4,684 shares in the last quarter. O Shaughnessy Asset Management LLC purchased a new stake in Genpact in the 3rd quarter worth $305,000. Trexquant Investment LP increased its stake in Genpact by 630.0% in the 3rd quarter. Trexquant Investment LP now owns 47,234 shares of the business services provider’s stock worth $1,710,000 after buying an additional 40,764 shares in the last quarter. Tower Research Capital LLC TRC increased its stake in Genpact by 63.9% in the 3rd quarter. Tower Research Capital LLC TRC now owns 18,439 shares of the business services provider’s stock worth $667,000 after buying an additional 7,189 shares in the last quarter. Finally, Truist Financial Corp grew its position in shares of Genpact by 1,624.0% during the third quarter. Truist Financial Corp now owns 350,400 shares of the business services provider’s stock valued at $12,684,000 after purchasing an additional 330,075 shares in the last quarter. Hedge funds and other institutional investors own 96.03% of the company’s stock.

Genpact Stock Performance

G stock opened at $32.03 on Tuesday. The stock has a market capitalization of $5.76 billion, a PE ratio of 9.15, a price-to-earnings-growth ratio of 1.51 and a beta of 1.11. Genpact has a 12-month low of $29.41 and a 12-month high of $39.58. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.36. The stock’s 50 day simple moving average is $32.47 and its 200 day simple moving average is $33.57.

Genpact (NYSE:GGet Free Report) last released its quarterly earnings results on Thursday, May 9th. The business services provider reported $0.68 earnings per share for the quarter, beating the consensus estimate of $0.62 by $0.06. The firm had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.11 billion. Genpact had a return on equity of 22.71% and a net margin of 14.21%. As a group, research analysts forecast that Genpact will post 2.7 earnings per share for the current fiscal year.

Genpact Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 26th. Shareholders of record on Monday, June 10th were paid a $0.153 dividend. The ex-dividend date was Monday, June 10th. This represents a $0.61 dividend on an annualized basis and a yield of 1.91%. Genpact’s payout ratio is presently 17.43%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on G shares. StockNews.com lowered Genpact from a “strong-buy” rating to a “buy” rating in a research note on Friday, April 5th. BMO Capital Markets lowered their target price on Genpact from $39.00 to $38.00 and set a “market perform” rating for the company in a research note on Friday, May 10th. Needham & Company LLC reissued a “buy” rating and issued a $40.00 target price on shares of Genpact in a research note on Friday, May 10th. Citigroup lowered their target price on Genpact from $36.00 to $33.00 and set a “neutral” rating for the company in a research note on Monday, April 22nd. Finally, Wedbush reiterated a “neutral” rating and set a $35.00 target price on shares of Genpact in a report on Friday, May 10th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, Genpact currently has an average rating of “Hold” and an average target price of $38.00.

Check Out Our Latest Research Report on Genpact

Genpact Company Profile

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.